| scholarly article | Q13442814 |
| P2093 | author name string | Vestberg M | |
| Teyton L | |||
| Jackson MR | |||
| Lechler RI | |||
| Karlsson L | |||
| Peterson PA | |||
| Vaughan JH | |||
| Aichinger G | |||
| P2860 | cites work | The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3 | Q24303524 |
| Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide | Q27731272 | ||
| Expression of wild-type and mutant forms of influenza hemagglutinin: the role of folding in intracellular transport | Q27865283 | ||
| ER degradation of a misfolded luminal protein by the cytosolic ubiquitin-proteasome pathway | Q27932376 | ||
| Mice lacking the MHC class II-associated invariant chain | Q28507606 | ||
| Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression | Q28585705 | ||
| Protein folding in the cell | Q29547792 | ||
| Presentation of newly synthesized glycoproteins to CD4+ T lymphocytes. An analysis using influenza hemagglutinin transport mutants | Q30466290 | ||
| Membrane insertion and oligomeric assembly of HLA-DR histocompatibility antigens | Q34273916 | ||
| Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. | Q34350288 | ||
| In the absence of the invariant chain, HLA-DR molecules display a distinct array of peptides which is influenced by the presence or absence of HLA-DM | Q36158655 | ||
| Assembly of influenza hemagglutinin trimers and its role in intracellular transport | Q36215440 | ||
| Anti-peptide antibodies detect steps in a protein conformational change: low-pH activation of the influenza virus hemagglutinin | Q36217109 | ||
| Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: intrinsic sensitivity and the role of subunit assembly | Q36220205 | ||
| Quality control in the secretory pathway: retention of a misfolded viral membrane glycoprotein involves cycling between the ER, intermediate compartment, and Golgi apparatus | Q36234402 | ||
| Assembly of ER-associated protein degradation in vitro: dependence on cytosol, calnexin, and ATP. | Q36236461 | ||
| Decrease in macrophage antigen catabolism caused by ammonia and chloroquine is associated with inhibition of antigen presentation to T cells | Q36275163 | ||
| Chloroquine affects biosynthesis of Ia molecules by inhibiting dissociation of invariant (gamma) chains from alpha-beta dimers in B cells | Q36350981 | ||
| Efficient cell surface expression of class II MHC molecules in the absence of associated invariant chain | Q36353030 | ||
| Cell surface expression of class II histocompatibility antigens occurs in the absence of the invariant chain | Q36353070 | ||
| Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles | Q36361966 | ||
| Determinant capture as a possible mechanism of protection afforded by major histocompatibility complex class II molecules in autoimmune disease | Q36362580 | ||
| Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal | Q36362597 | ||
| Folding of influenza hemagglutinin in the endoplasmic reticulum | Q36530148 | ||
| Empty and peptide-containing conformers of class I major histocompatibility complex molecules expressed in Drosophila melanogaster cells | Q37351477 | ||
| Class II-restricted presentation of an endogenously derived immunodominant T-cell determinant of hen egg lysozyme | Q37482282 | ||
| Invariant chain targets HLA class II molecules to acidic endosomes containing internalized influenza virus | Q37545426 | ||
| Structural basis of immune recognition of influenza virus hemagglutinin | Q37925554 | ||
| Protein degradation in the endoplasmic reticulum | Q37947738 | ||
| Quality control in the secretory pathway | Q40380586 | ||
| Characterization and use of the Drosophila metallothionein promoter in cultured Drosophila melanogaster cells | Q40537087 | ||
| Invariant chain structure and MHC class II function | Q40968427 | ||
| Human self-reactive T cell clones expressing identical T cell receptor beta chains differ in their ability to recognize a cryptic self-epitope | Q41234208 | ||
| Antigen presentation mediated by recycling of surface HLA-DR molecules. | Q41335304 | ||
| The invariant chain inhibits presentation of endogenous antigens by a human fibroblast cell line | Q41456815 | ||
| The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide | Q41640226 | ||
| Diversity of endogenous epitopes bound to MHC class II molecules limited by invariant chain | Q41660992 | ||
| Processed antigen binds to newly synthesized MHC class II molecules in antigen-specific B lymphocytes | Q41661580 | ||
| MHC class II-restricted presentation of intracellular antigen | Q41694984 | ||
| The minimal number of class II MHC-antigen complexes needed for T cell activation | Q41724410 | ||
| Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding | Q41731115 | ||
| A single amino acid change in the cytoplasmic domain allows the influenza virus hemagglutinin to be endocytosed through coated pits | Q45839792 | ||
| Intracellular transport of class II MHC molecules directed by invariant chain. | Q45941447 | ||
| Short cytoplasmic sequences serve as retention signals for transmembrane proteins in the endoplasmic reticulum | Q46051539 | ||
| Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways | Q46424023 | ||
| Transient aggregation of major histocompatibility complex class II chains during assembly in normal spleen cells. | Q49164800 | ||
| A role for peptide in determining MHC class II structure | Q59077345 | ||
| Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules | Q59096640 | ||
| Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains | Q59662175 | ||
| Immunodominance with progenitor B cell diversity in the neutralizing antibody repertoire to influenza infection | Q60344714 | ||
| Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures | Q68812264 | ||
| Construction of influenza haemagglutinin genes that code for intracellular and secreted forms of the protein | Q70522566 | ||
| Allelic differences affecting invariant chain dependency of MHC class II subunit assembly | Q72112282 | ||
| Poor loading of major histocompatibility complex class II molecules with endogenously synthesized short peptides in the absence of invariant chain | Q72508379 | ||
| P433 | issue | 46 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 29127-29136 | |
| P577 | publication date | 1997-11-01 | |
| P1433 | published in | Journal of Biological Chemistry | Q867727 |
| P1476 | title | Major histocompatibility complex class II-dependent unfolding, transport, and degradation of endogenous proteins | |
| P478 | volume | 272 |
| Q42015843 | A Peptide/MHCII conformer generated in the presence of exchange peptide is substrate for HLA-DM editing |
| Q33840502 | Accessory molecules for MHC class II peptide loading |
| Q37219526 | Autophagy in CD4+ T-cell immunity and tolerance. |
| Q27489559 | Autophagy, antiviral immunity, and viral countermeasures |
| Q40796821 | Beryllium binding to HLA-DP molecule carrying the marker of susceptibility to berylliosis glutamate beta 69. |
| Q37958695 | Beyond the classical: influenza virus and the elucidation of alternative MHC class II-restricted antigen processing pathways |
| Q38588610 | Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases |
| Q36510519 | Chaperone-mediated autophagy in aging and disease |
| Q40616521 | Detailed analysis of the effects of Glu/Lys beta69 human leukocyte antigen-DP polymorphism on peptide-binding specificity |
| Q34579769 | Diversity in MHC class II antigen presentation |
| Q34895151 | Evasion of host immunity directed by papillomavirus-encoded proteins |
| Q36899098 | Experimental discovery of T-cell epitopes: combining the best of classical and contemporary approaches |
| Q47809308 | Expression of recombinant anti-E-selectin single-chain Fv antibody fragments in stably transfected insect cell lines. |
| Q36296166 | Immune surveillance of intracellular pathogens via autophagy |
| Q54436860 | Immunodominant T-cell epitopes of hnRNP-A2 associated with disease activity in patients with rheumatoid arthritis. |
| Q36655722 | LAMP-2C Inhibits MHC Class II Presentation of Cytoplasmic Antigens by Disrupting Chaperone-Mediated Autophagy |
| Q35076771 | Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways |
| Q35145091 | Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii |
| Q37780705 | Prospects of a novel vaccination strategy for human gamma-herpesviruses |
| Q40732361 | Stabilization of soluble, low-affinity HLA-DM/HLA-DR1 complexes by leucine zippers |
| Q35609768 | T cell-based therapies for EBV-associated malignancies |
| Q33815445 | The role of H2-O and HLA-DO in major histocompatibility complex class II-restricted antigen processing and presentation |
| Q39832869 | Uveal melanoma cell-based vaccines express MHC II molecules that traffic via the endocytic and secretory pathways and activate CD8+ cytotoxic, tumor-specific T cells. |
| Q36228485 | Virus-specific CD4+ T cells: ready for direct attack |
Search more.